Literature DB >> 8823079

Talc pleurodesis: talc slurry versus thoracoscopic talc insufflation in a porcine model.

R G Cohen1, W W Shely, S E Thompson, J A Hagen, C C Marboe, T R DeMeester, V A Starnes.   

Abstract

BACKGROUND: Pleurodesis using both talc slurry and thoracoscopic talc insufflation has been shown to be clinically effective. This study compares these two modalities of pleural talc instillation in an animal model.
METHODS: Eleven immature pigs underwent general endotracheal anesthesia. On one side, a slurry of 5 g sterile United States Pharmacopeia talc in 50 mL of saline solution was instilled through a thoracostomy tube. On the other side, the lung was deflated and 5 g of dry talc was insufflated under thoracoscopic visualization. The animals were sacrificed 30 days later, and the quality of pleural adhesions was graded from 0 to 2 (0 = absent; 1 = light; 2 = dense) in each of six regions of each hemithorax. The distribution of adhesions on each side was graded from 0 to 6, according to the number of areas that contained adhesions.
RESULTS: One animal died of anesthetic complications. Among the survivors, adhesions produced by both methods were dense and diffuse in 8 of 10 animals, and light and diffuse in 1 animal. One animal had light or absent adhesions on the talc slurry side, and dense and diffuse adhesions on the thoracoscopic talc insufflation side. There was no difference between the techniques for density of adhesion scores (talc slurry, 9.9 +/- 2.2; thoracoscopic talc insufflation, 10.0 +/- 2.5) or distribution of adhesion scores (talc slurry, 5.5 +/- 1.0; thoracoscopic talc insufflation, 5.8 +/- 0.4) (p > 0.1).
CONCLUSIONS: Effective pleurodesis in a porcine model can be obtained with either talc slurry or thoracoscopic talc insufflation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823079     DOI: 10.1016/0003-4975(96)00488-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients.

Authors:  K Arapis; R Caliandro; J-B Stern; P Girard; D Debrosse; D Gossot
Journal:  Surg Endosc       Date:  2006-05-02       Impact factor: 4.584

2.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

3.  Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.

Authors:  Nobuaki Matsubara; Kuniaki Itoh; Hirofumi Mukai; Shunji Nagai
Journal:  Int J Clin Oncol       Date:  2011-10-07       Impact factor: 3.402

4.  Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications.

Authors:  Y C Lee; K B Lane; R E Parker; D S Ayo; J T Rogers; R W Diters; P J Thompson; R W Light
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

5.  Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis.

Authors:  Gadi Lending; Yousef Abed El Ghani; Edward Kaykov; Boris Svirsky; Hector Isaac Cohen; Edward Altman
Journal:  Indian J Surg Oncol       Date:  2020-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.